Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma

The programmed cell death 1/programmed cell death 1 ligand 1 pathway was successfully targeted in cancer immunotherapy. Elevated interleukin‐17 (IL‐17), which is known in autoimmune diseases, has recently been recognized in cancer patients. We investigated the role of IL‐17 in the regulation of expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Aotsuka, Aeri, Matsumoto, Yoko, Arimoto, Takahide, Kawata, Akira, Ogishima, Juri, Taguchi, Ayumi, Tanikawa, Michihiro, Sone, Kenbun, Mori‐Uchino, Mayuyo, Tsuruga, Tetsushi, Oda, Katsutoshi, Kawana, Kei, Osuga, Yutaka, Fujii, Tomoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778630/
https://www.ncbi.nlm.nih.gov/pubmed/31432577
http://dx.doi.org/10.1111/cas.14174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778630/
https://www.ncbi.nlm.nih.gov/pubmed/31432577
http://dx.doi.org/10.1111/cas.14174

Ejemplares similares